In a series of corporate actions, both Jaro Institute of Technology Management and Research Limited and Tata Consultancy Services Limited (TCS) have declared significant dividend payouts. These announcements offer insights for investors and highlight the current financial health of these companies.
Jaro Institute of Technology Management and Research Limited has declared an interim dividend of Rs 2 per share, with a face value of Rs 10. The ex-date for this dividend is set for January 16, 2026. This means that shareholders who own shares of Jaro Institute on or before this date will be eligible to receive the dividend. This distribution is a way for the company to share its profits with its shareholders.
Tata Consultancy Services Limited (TCS) has also announced dividends, with the same ex-date of January 16, 2026. TCS has declared an interim dividend of Rs 11 per share, alongside a special dividend of Rs 46 per share. The face value of TCS shares is Rs 1. The record date, which is the date used to determine the shareholders eligible for the dividend, is January 17, 2026. This significant payout reflects TCS’s strong financial performance and its commitment to rewarding its shareholders. The dual dividend approach, including a special dividend, often indicates a particularly profitable period for the company.
These corporate actions, including both interim and special dividends, are typical ways for companies to distribute profits to their shareholders. The ex-date is a crucial date for investors, as it determines when they need to own the shares to be eligible for the dividend.
Key Takeaways:
- Jaro Institute and TCS have announced dividends.
- The ex-date for both companies is January 16, 2026.
- TCS is offering a special dividend alongside its interim dividend.
- The record date for TCS is January 17, 2026.
This news is important for investors in the stock market, particularly those holding shares in Jaro Institute and TCS. These announcements are part of ongoing financial news, and investors should stay informed about such corporate actions to make informed decisions.
About the Author
